{
    "clinical_study": {
        "@rank": "100633", 
        "arm_group": [
            {
                "arm_group_label": "virtual reality glasses and Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "virtual reality glasses and 5 ml Lidocaine 2%"
            }, 
            {
                "arm_group_label": "Lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "5 cc Lidocaine2%"
            }
        ], 
        "brief_summary": {
            "textblock": "In recent studies using virtual reality has been  proposed as a non pharmacological methods\n      for pain relief but until this time , its effects has not been assessed  on pain and anxiety\n      during episiotomy repair. To determine  the effectiveness of virtual reality Glasses on pain\n      and anxiety in Primiparity women during episiotomy repair."
        }, 
        "brief_title": "The Effect of Virtual Reality Glasses on Pain and Anxiety", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Pain and Anxiety", 
        "condition_browse": {
            "mesh_term": "Anxiety Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Iranian\n\n          -  low risk pregnancy\n\n          -  Apgar \u2265 7\n\n        Exclusion Criteria:\n\n          -  vision or ear disorders\n\n          -  History of motion sickness or headaches\n\n          -  psychological disease or Addiction\n\n          -  Prescribe  narcotic or sedation 4hour  prior to  delivery."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "34 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01659359", 
            "org_study_id": "virtual reality glasses"
        }, 
        "intervention": [
            {
                "arm_group_label": "virtual reality glasses and Lidocaine", 
                "description": "The samples were randomly allocated to use Virtual reality glasses and 5 ml Lidocaine2% for decreasing pain and anxiety in episiotomy repair.", 
                "intervention_name": "Virtual reality glasses and Lidocaine", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Lidocaine", 
                "description": "The samples were randomly allocated to use 5 ml Lidocaine2% for decreasing pain and anxiety in episiotomy repair.", 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methamphetamine", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 7, 2012", 
        "number_of_arms": "2", 
        "official_title": "Vice-presidency for Research", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Virtual reality glasses decreased pain and anxiety during episiotomy", 
            "safety_issue": "Yes", 
            "time_frame": "up to 8 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01659359"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mashhad University of Medical Sciences", 
            "investigator_full_name": "Samira Ebrahimzadeh Zagami", 
            "investigator_title": "Principle Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Mashhad University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mashhad University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}